Evaluation of a population-based screening for type 2 diabetes: a community-based screening project in Puli, Taiwan - PubMed (original) (raw)
Comparative Study
. 2000 Oct;31(4):396-402.
doi: 10.1006/pmed.2000.0728.
Affiliations
- PMID: 11006065
- DOI: 10.1006/pmed.2000.0728
Comparative Study
Evaluation of a population-based screening for type 2 diabetes: a community-based screening project in Puli, Taiwan
H J Chang et al. Prev Med. 2000 Oct.
Abstract
Background: A Markov method incorporating the relationships between prevalence, incidence, and mortality with respect to type 2 diabetes was used to assess a population-based screening for this disease.
Methods: Data from a population-based screening project for residents of Puli, Taiwan, over 30 years of age (n= 1,219) were used to estimate the annual incidence of asymptomatic type 2 diabetes, the prevalence to incidence (P/I) ratio, and the hazard rate of death due to type 2 diabetes. These parameters were employed to develop a Markov process to evaluate the effects of early detection of type 2 diabetes on the risk of death from this disease in a simulated population (n= 10,000) receiving biennial, 5-year interval, or no screening.
Results: The estimated annual incidence, average duration from asymptomatic to symptomatic type 2 diabetes (P/I ratio), and hazard rate for death from this disease were 0.86% (95% CI 0.50-1.48), 10 years (95% CI 7.69-14.01), and 1.1% per year, respectively. This yields an optimal screening interval of 5 years. Simulation of a 5-year interval screening regimen versus no screen ing yielded a relative risk reduction of 31% (95% CI 12-46%). A similar value was found for a biennial screening regime.
Conclusions: The results suggest that early detection of type 2 diabetes via a community-based screening project in developing countries with high prevalence is worthwhile.
Copyright 2000 American Health Foundation and Academic Press.
Similar articles
- Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.
Ringborg A, Lindgren P, Martinell M, Yin DD, Schön S, Stålhammar J. Ringborg A, et al. Diabet Med. 2008 Oct;25(10):1178-86. doi: 10.1111/j.1464-5491.2008.02541.x. Diabet Med. 2008. PMID: 19046196 - A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B, Rodby RA. Palmer AJ, et al. Nephrol Dial Transplant. 2008 Apr;23(4):1216-23. doi: 10.1093/ndt/gfn082. Nephrol Dial Transplant. 2008. PMID: 18359872 Clinical Trial. - A Markov chain model to assess the efficacy of screening for non-insulin dependent diabetes mellitus (NIDDM).
Kuo HS, Chang HJ, Chou P, Teng L, Chen TH. Kuo HS, et al. Int J Epidemiol. 1999 Apr;28(2):233-40. doi: 10.1093/ije/28.2.233. Int J Epidemiol. 1999. PMID: 10342684 - Epidemiology of type 2 diabetes in Taiwan.
Chou P, Li CL, Tsai ST. Chou P, et al. Diabetes Res Clin Pract. 2001 Nov;54 Suppl 1:S29-35. doi: 10.1016/s0168-8227(01)00306-0. Diabetes Res Clin Pract. 2001. PMID: 11580966 Review.
Cited by
- A Population Dynamic Model to Assess the Diabetes Screening and Reporting Programs and Project the Burden of Undiagnosed Diabetes in Thailand.
Mahikul W, White LJ, Poovorawan K, Soonthornworasiri N, Sukontamarn P, Chanthavilay P, Pan-Ngum W, Medley GF. Mahikul W, et al. Int J Environ Res Public Health. 2019 Jun 21;16(12):2207. doi: 10.3390/ijerph16122207. Int J Environ Res Public Health. 2019. PMID: 31234452 Free PMC article. - Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.
Simmons RK, Griffin SJ, Lauritzen T, Sandbæk A. Simmons RK, et al. Diabetologia. 2017 Nov;60(11):2192-2199. doi: 10.1007/s00125-017-4299-y. Epub 2017 Aug 23. Diabetologia. 2017. PMID: 28831539 Free PMC article. Clinical Trial. - Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults.
Simmons RK, Griffin SJ, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbæk A. Simmons RK, et al. Diabetologia. 2017 Nov;60(11):2183-2191. doi: 10.1007/s00125-017-4323-2. Epub 2017 Aug 23. Diabetologia. 2017. PMID: 28831535 Free PMC article. Clinical Trial. - Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.
Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ. Simmons RK, et al. Lancet. 2012 Nov 17;380(9855):1741-8. doi: 10.1016/S0140-6736(12)61422-6. Epub 2012 Oct 4. Lancet. 2012. PMID: 23040422 Free PMC article. Clinical Trial. - Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.
Simmons RK, Rahman M, Jakes RW, Yuyun MF, Niggebrugge AR, Hennings SH, Williams DR, Wareham NJ, Griffin SJ. Simmons RK, et al. Diabetologia. 2011 Feb;54(2):312-9. doi: 10.1007/s00125-010-1949-8. Epub 2010 Oct 27. Diabetologia. 2011. PMID: 20978739
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous